287 related articles for article (PubMed ID: 21572265)
1. Hepatocellular carcinoma arising in a pigmented telangiectatic adenoma with nuclear β-catenin and glutamine synthetase positivity: case report and review of the literature.
Hechtman JF; Raoufi M; Fiel MI; Taouli B; Facciuto M; Schiano TD; Blouin AG; Thung SN
Am J Surg Pathol; 2011 Jun; 35(6):927-32. PubMed ID: 21572265
[TBL] [Abstract][Full Text] [Related]
2. Hepatocellular carcinoma arising in a telangiectatic hepatocellular adenoma.
González-Lara MF; Córdova-Ramón JC; Gamboa-Domínguez A; Cosme-Labarthe J; Carrillo-Pérez DL
Ann Hepatol; 2013; 12(4):626-8. PubMed ID: 23813141
[TBL] [Abstract][Full Text] [Related]
3. Nuclear beta-catenin staining and absence of steatosis are indicators of hepatocellular adenomas with an increased risk of malignancy.
Van der Borght S; Libbrecht L; Katoonizadeh A; Aerts R; Nevens F; Verslype C; Roskams TA
Histopathology; 2007 Dec; 51(6):855-6. PubMed ID: 17903198
[No Abstract] [Full Text] [Related]
4. Hepatocellular adenoma subtype classification using molecular markers and immunohistochemistry.
Bioulac-Sage P; Rebouissou S; Thomas C; Blanc JF; Saric J; Sa Cunha A; Rullier A; Cubel G; Couchy G; Imbeaud S; Balabaud C; Zucman-Rossi J
Hepatology; 2007 Sep; 46(3):740-8. PubMed ID: 17663417
[TBL] [Abstract][Full Text] [Related]
5. Hepatocellular adenomas in a large community population, 2000 to 2010: reclassification per current World Health Organization classification and results of long-term follow-up.
Shafizadeh N; Genrich G; Ferrell L; Kakar S
Hum Pathol; 2014 May; 45(5):976-83. PubMed ID: 24746201
[TBL] [Abstract][Full Text] [Related]
6. Validation of a liver adenoma classification system in a tertiary referral centre: implications for clinical practice.
van Aalten SM; Verheij J; Terkivatan T; Dwarkasing RS; de Man RA; Ijzermans JN
J Hepatol; 2011 Jul; 55(1):120-5. PubMed ID: 21145863
[TBL] [Abstract][Full Text] [Related]
7. A Limited Immunohistochemical Panel Can Subtype Hepatocellular Adenomas for Routine Practice.
Larson BK; Guindi M
Am J Clin Pathol; 2017 Jun; 147(6):557-570. PubMed ID: 28472207
[TBL] [Abstract][Full Text] [Related]
8. Correlation of exon 3 β-catenin mutations with glutamine synthetase staining patterns in hepatocellular adenoma and hepatocellular carcinoma.
Hale G; Liu X; Hu J; Xu Z; Che L; Solomon D; Tsokos C; Shafizadeh N; Chen X; Gill R; Kakar S
Mod Pathol; 2016 Nov; 29(11):1370-1380. PubMed ID: 27469330
[TBL] [Abstract][Full Text] [Related]
9. Genotype-phenotype correlation in hepatocellular adenoma: new classification and relationship with HCC.
Zucman-Rossi J; Jeannot E; Nhieu JT; Scoazec JY; Guettier C; Rebouissou S; Bacq Y; Leteurtre E; Paradis V; Michalak S; Wendum D; Chiche L; Fabre M; Mellottee L; Laurent C; Partensky C; Castaing D; Zafrani ES; Laurent-Puig P; Balabaud C; Bioulac-Sage P
Hepatology; 2006 Mar; 43(3):515-24. PubMed ID: 16496320
[TBL] [Abstract][Full Text] [Related]
10. Diffuse glutamine synthetase overexpression restricted to areas of peliosis in a β-catenin-activated hepatocellular adenoma: a potential pitfall in glutamine synthetase interpretation.
Berry RS; Gullapalli RR; Wu J; Morris K; Hanson JA
Virchows Arch; 2014 Aug; 465(2):241-5. PubMed ID: 24997695
[TBL] [Abstract][Full Text] [Related]
11. β-catenin activated hepatocellular adenoma.
Chu HH; Moon WS
Clin Mol Hepatol; 2013 Jun; 19(2):185-9. PubMed ID: 23837144
[No Abstract] [Full Text] [Related]
12. Diagnosis of well-differentiated hepatocellular lesions: role of immunohistochemistry and other ancillary techniques.
Shafizadeh N; Kakar S
Adv Anat Pathol; 2011 Nov; 18(6):438-45. PubMed ID: 21993269
[TBL] [Abstract][Full Text] [Related]
13. Endothelial cell differentiation in hepatocellular adenomas: implications for histopathological diagnosis.
Gouysse G; Frachon S; Hervieu V; Fiorentino M; d'Errico A; Dumortier J; Boillot O; Partensky C; Grigioni WF; Scoazec JY
J Hepatol; 2004 Aug; 41(2):259-66. PubMed ID: 15288475
[TBL] [Abstract][Full Text] [Related]
14. Pigmented hepatocellular adenoma with β-catenin activation: case report and literature review.
Coelho R; Gonçalves R; Carneiro F; Fernandes M; Lopes J; Guimarães S; Macedo G
Ann Hepatol; 2016; 15(4):598-603. PubMed ID: 27236161
[TBL] [Abstract][Full Text] [Related]
15. A case of β-catenin-positive hepatocellular adenoma with MR imaging sign of diffuse intratumoral fat deposition.
Ishii M; Kazaoka J; Fukushima J; Gunji M; Aoyama T; Fukusato T; Sano K; Kondo F; Takeshita T; Furui S; Akahane M
Abdom Imaging; 2015 Aug; 40(6):1487-91. PubMed ID: 25875860
[TBL] [Abstract][Full Text] [Related]
16. The enigma of glutamine synthetase and b-catenin expression in hepatocellular adenoma in familial adenomatous polyposis coli.
Gouw ASH; Sempoux C; Bioulac-Sage P
Virchows Arch; 2024 Apr; 484(4):553-554. PubMed ID: 38453738
[No Abstract] [Full Text] [Related]
17. Revisiting the pathology of resected benign hepatocellular nodules using new immunohistochemical markers.
Bioulac-Sage P; Cubel G; Balabaud C; Zucman-Rossi J
Semin Liver Dis; 2011 Feb; 31(1):91-103. PubMed ID: 21344354
[TBL] [Abstract][Full Text] [Related]
18. [Malignant transformation of hepatocellular adenoma in men].
Goudard Y; Rouquie D; Bertocchi C; Daligand H; Baton O; Lahutte M; Terris B; Baranger B
Gastroenterol Clin Biol; 2010 Mar; 34(3):168-70. PubMed ID: 20189337
[No Abstract] [Full Text] [Related]
19. Glutamine synthetase immunostaining correlates with pathologic features of hepatocellular carcinoma and better survival after radiofrequency thermal ablation.
Dal Bello B; Rosa L; Campanini N; Tinelli C; Torello Viera F; D'Ambrosio G; Rossi S; Silini EM
Clin Cancer Res; 2010 Apr; 16(7):2157-66. PubMed ID: 20233882
[TBL] [Abstract][Full Text] [Related]
20. Hepatocellular nodules expressing markers of hepatocellular adenomas in Budd-Chiari syndrome and other rare hepatic vascular disorders.
Sempoux C; Paradis V; Komuta M; Wee A; Calderaro J; Balabaud C; Quaglia A; Bioulac-Sage P
J Hepatol; 2015 Nov; 63(5):1173-80. PubMed ID: 26119687
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
